New Microchannel Device Measures Blood Viscosity
|
By HospiMedica International staff writers Posted on 21 Sep 2017 |

Image: UConn researchers George Lykotrafitis and Kostyantyn Partola with the whole blood rheometer (Photo courtesy of Sean Flynn / UConn).
An innovative optical device can measure blood viscosity at the point of care, providing an early warning sign of a potential cardiovascular event.
Developed by researchers at the University of Connecticut (UConn; Storrs, USA), the whole blood rheometer measures blood viscosity by extrapolation of the time it takes blood to travel through a disposable transparent microchannel card. To perform the test, a droplet of blood is placed on the card; blood then wicks into the microchannel under capillary pressure. The microchannel card is then placed between a light source and a photodiode detector, with the velocity of the wicking blood converted into a viscosity reading that indicates elevated risk for cardiac events.
Once the test is completed, the used microchannel card is discarded and replaced with a new one. Since the device itself never comes in contact with the biological sample, practitioners don’t need to sterilize it in between patients or worry about cross-contamination. According to the researchers, current blood viscosity tests involve a mechanical rheometer, which requires large samples, takes much longer, and needs to be sterilized between tests. In addition, the travel time between the medical office and the test facility means that samples are often no longer reliable.
“We were very surprised that there is no commercial option to quickly and simply check this critical piece of information,” said George Lykotrafitis, PhD, an associate professor of mechanical engineering and co-inventor of the device. “The research shows there is a connection between blood viscosity and cardiac events, and the equipment exists to test it, but not in a practical or efficient way. We decided to try to solve the problem.”
“Our technology really is plug-and-play, but the impact is significant. With this information, doctors can suggest simple life-style changes on the spot to prevent their patients from having a stroke or heart attack,” concluded co-inventor Kostyantyn Partola, MSc, who added that they are in early discussions with physicians at UConn Health and Yale University School of Medicine (Yale; New Haven, CT, USA) to conduct clinical trials.
Blood behaves as a non-Newtonian fluid (a fluid that does not follow Newton's Law of Viscosity). In a Newtonian fluid, the relation between the shear stress and the shear rate is linear, with the constant of proportionality being the coefficient of viscosity. In a non-Newtonian fluid, the relationship between shear stress and shear rate shifts, and a constant coefficient of viscosity cannot be defined. Since the velocity of blood differs when pumping and at rest, it’s viscosity also changes. Other examples of non-Newtonian fluids include paint, ketchup, toothpaste, starch suspensions, and shampoo.
Related Links:
University of Connecticut
Yale University School of Medicine
Developed by researchers at the University of Connecticut (UConn; Storrs, USA), the whole blood rheometer measures blood viscosity by extrapolation of the time it takes blood to travel through a disposable transparent microchannel card. To perform the test, a droplet of blood is placed on the card; blood then wicks into the microchannel under capillary pressure. The microchannel card is then placed between a light source and a photodiode detector, with the velocity of the wicking blood converted into a viscosity reading that indicates elevated risk for cardiac events.
Once the test is completed, the used microchannel card is discarded and replaced with a new one. Since the device itself never comes in contact with the biological sample, practitioners don’t need to sterilize it in between patients or worry about cross-contamination. According to the researchers, current blood viscosity tests involve a mechanical rheometer, which requires large samples, takes much longer, and needs to be sterilized between tests. In addition, the travel time between the medical office and the test facility means that samples are often no longer reliable.
“We were very surprised that there is no commercial option to quickly and simply check this critical piece of information,” said George Lykotrafitis, PhD, an associate professor of mechanical engineering and co-inventor of the device. “The research shows there is a connection between blood viscosity and cardiac events, and the equipment exists to test it, but not in a practical or efficient way. We decided to try to solve the problem.”
“Our technology really is plug-and-play, but the impact is significant. With this information, doctors can suggest simple life-style changes on the spot to prevent their patients from having a stroke or heart attack,” concluded co-inventor Kostyantyn Partola, MSc, who added that they are in early discussions with physicians at UConn Health and Yale University School of Medicine (Yale; New Haven, CT, USA) to conduct clinical trials.
Blood behaves as a non-Newtonian fluid (a fluid that does not follow Newton's Law of Viscosity). In a Newtonian fluid, the relation between the shear stress and the shear rate is linear, with the constant of proportionality being the coefficient of viscosity. In a non-Newtonian fluid, the relationship between shear stress and shear rate shifts, and a constant coefficient of viscosity cannot be defined. Since the velocity of blood differs when pumping and at rest, it’s viscosity also changes. Other examples of non-Newtonian fluids include paint, ketchup, toothpaste, starch suspensions, and shampoo.
Related Links:
University of Connecticut
Yale University School of Medicine
Latest Critical Care News
- Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreSurgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







